中国医药工业杂志2024,Vol.55Issue(4) :488-493.DOI:10.16522/j.cnki.cjph.2024.04.006

吸入制剂用原料药中无定型含量的定量方法研究进展

Research Progress on Quantification Methods of Amorphous Content of Bulk Drugs for Inhaled Preparation

齐创宇
中国医药工业杂志2024,Vol.55Issue(4) :488-493.DOI:10.16522/j.cnki.cjph.2024.04.006

吸入制剂用原料药中无定型含量的定量方法研究进展

Research Progress on Quantification Methods of Amorphous Content of Bulk Drugs for Inhaled Preparation

齐创宇1
扫码查看

作者信息

  • 1. 上海新黄河制药有限公司,上海 201612
  • 折叠

摘要

吸入制剂尤其是吸入粉雾剂的快速发展,凸显了对微粉化原料药中无定型含量的定量需求.文章简述了目前广泛使用的7种定量方法(PXRD法、DSC法、动态蒸汽吸附法、微量热法、溶解量热法、IR法和拉曼光谱法),及其限度和相应的检测仪器,并基于吸入制剂用原料药的常见无定型含量限度要求,列举了一些研究实例,分析了不同方法的优缺点,以期为相关研究提供参考.

Abstract

The rapid development of inhaled products,especially dry powder for inhalation,highlights the quantitative demands for the amorphous content of micronized bulk drugs.This review briefly describes seven widely used quantitative methods,named PXRD,DSC,dynamic vapor adsorption,microcalorimetry,solution calorimetry,IR and Raman spectroscopy methods,as well as their limitations and corresponding detection instruments.And based on the common limit requirements of amorphous content for inhaled bulk drugs,some examples are provided.The advantages and disadvantages of different methods are analyzed to provide some references for related researches.

关键词

吸入制剂/微粉化原料药/无定型含量/定量分析/结晶度

Key words

inhaled preparation/micronized bulk drug/amorphous content/quantification analysis/crystallinity

引用本文复制引用

出版年

2024
中国医药工业杂志
上海医药工业研究院,中国化学制药工业协会

中国医药工业杂志

CSTPCDCSCD
影响因子:0.487
ISSN:1001-8255
参考文献量32
段落导航相关论文